Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134759) titled 'A real-world study on treatment adherence, symptom trajectories, and survival prognosis in patients with solid tumors' on Oct. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Mianyang Central Hospital
Condition:
solid malignant tumor
Intervention:
Targeted therapy group:None
Combination Therapy Group:None
Immunotherapy group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-31
Target Sample Size: Targeted therapy group:500;Combination Therapy Group:500;Immunotherapy group:500;chemotherapy group:500;
Countries of Recruitment:
China
...